Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-8260
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus ; volume:2 ; number:1 ; day:12 ; month:4 ; year:2016 ; pages:1-9 ; date:12.2016
Clinical diabetes and endocrinology ; 2, Heft 1 (12.4.2016), 1-9, 12.2016
- Creator
-
Portillo-Sanchez, Paola
- Contributor
-
Cusi, Kenneth
SpringerLink (Online service)
- DOI
-
10.1186/s40842-016-0027-7
- URN
-
urn:nbn:de:1111-2016041313515
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Portillo-Sanchez, Paola
- Cusi, Kenneth
- SpringerLink (Online service)
Other Objects (12)
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet